Pembahasan HASIL PENELITIAN DAN PEMBAHASAN
Irwan,2012.PROFILIMUNOPOSITIVITAS PROTEIN EBV PADA PENDERITAKARSINOMA NASOFARING DAN INDIVIDU SEHAT BERISIKO.
Available from :
http:eprints.undip.ac.id375591Irwan_N-G2A008099- LAPORAN_KTI.pdf
[Accessed 13 May 2013] N. Al-Rajhi,1 M. El-Sebaie,1 Y. Khafaga,1 A. AlZahrani,1 G. Mohamed2 and A. Al-
Amro1,2009. Eastern Mediterranean Health Journal, Vol. 15, No. 5.Nasopharyngeal carcinoma in Saudi Arabia: clinical presentation and
diagnostic delay.Available from :
http:applications.emro.who.int emhj150515_5_2009_1301_1307.pdf
[Accessed 19 May 2013]. National Cancer Institude 2009.Available from :
http:www.cancer.gov cancertopicspdqtreatmentnasopharyngealHealthProfessional
.[Accessed 17 April 2013].
Karsinoma Nasofaring.Available from :
journal.lib.unair.ac.idindex.php JKarticle...917
Kris., 2009. Kanker Nasofaring: kanker no 1 dibidang THT. Available from: http:thtkl.wordpress.com20090507kanker-nasofaring-kanker-no-1-di-
bidang-tht [Accessed 30 May 2012].
[Accessed 7 May 2013].
RS. Dharmais Pusat Kanker Nasional ,2009.Available from : http:www.
dharmais.co.idindex.phpkanker-nasofaring.html
S. Eva Singletary, Craig Allred, Pandora Ashley, Lawrence W. Bassett, Donald Berry, Kirby I. Bland, Patrick I. Borgen,Gary Clark, Stephen B. Edge, Daniel F. Hayes,
Lorie L. Hughes, Robert V.P. Hutter, Monica Morrow, David L. Page, Abram Recht, Richard L. Theriault, Ann Thor, Donald L. Weaver, H. Samuel Wieand,
and Frederick L. Greene,2002.Revision of the American Joint Committee on Cancer Staging System for Breast
Cancer.Available from : .[Accessed 2 May 2013].
http:jco.ascopubs.orgcontent2017 3628.full.pdf
[Accessed 21 May 2013]. Wulan,2012.Karakteristik Penderita Karsinoma Nasofaring .Available from
http:repository.usu.ac.idbitstream123456789215274Chapter20II.pdf. [Accessed
20 April 2013].
WA Kentjono , 2013.
WILIYANTO,2006. Insidensi Kanker Kepala Leher Berdasarkan Diagnosis Patologi Anatomi Di Rs Dr Kariadi Semarang.Available from :
Perkembangan Terkini Penatalaksanaan
http:eprints.undip.ac.id209981Onggo.pdf
[Accessed 14 May 2013]. Yenita, Aswiyanti Asri,2010.Korelasi antara Latent Membrane Protein-1 Virus
Epstein-Barr dengan P53 pada Karsinoma Nasofaring Penelitian Lanjutan. Available from:
http:jurnal.fk.unand.ac.idarticles vol_1no_101-05.pdf
.[ Accessed 22April 2013].
Lampiran 4. Hasil Analisis Data
Frequencies
Statistics
Umur Jenis
Kelamin Stadium
Keluhan Utama
Gejala Klinis
Tipe Histopatologi
Terapi penderita
N Valid
63 63
63 63
63 63
63 Missing
Frequency Table
Umur
Frequency Percent
Valid Percent Cumulative
Percent Valid
21-30 tahun 2
3.2 3.2
3.2 31-40 tahun
12 19.0
19.0 22.2
41-50 tahun 22
34.9 34.9
57.1 51-60 tahun
11 17.5
17.5 74.6
61-70 tahun 14
22.2 22.2
96.8 71-80 tahun
2 3.2
3.2 100.0
Umur
Frequency Percent
Valid Percent Cumulative
Percent Valid
21-30 tahun 2
3.2 3.2
3.2 31-40 tahun
12 19.0
19.0 22.2
41-50 tahun 22
34.9 34.9
57.1 51-60 tahun
11 17.5
17.5 74.6
61-70 tahun 14
22.2 22.2
96.8 71-80 tahun
2 3.2
3.2 100.0
Total 63
100.0 100.0
Jenis Kelamin
Frequency Percent
Valid Percent Cumulative
Percent Valid
Laki-laki 45
71.4 71.4
71.4 Perempuan
18 28.6
28.6 100.0
Total 63
100.0 100.0
Stadium
Frequency Percent
Valid Percent Cumulative
Percent Valid
Stadium I 2
3.2 3.2
3.2 Stadium II
8 12.7
12.7 15.9
Stadium III 39
61.9 61.9
77.8 Stadium IV
14 22.2
22.2 100.0
Total 63
100.0 100.0
Keluhan Utama
Frequency Percent
Valid Percent Cumulative
Percent Valid
Benjolan pada leher 26
41.3 41.3
41.3